- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Timing in Dentist-Patient Communication in Russian Federation
Total 13 results
-
National Research Center for Hematology, RussiaUnknownSeptic Shock | Nonchemotherapy Drug-induced Neutropenia | Neutropenia After Chemotherapy in Oncohematological Patients | Neutropenia in Patients With Aplastic AnemiaRussian Federation
-
Center of Personalized Medicine, PirogovaUniversity of Rochester; I.M. Sechenov First Moscow State Medical University; Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health and other collaboratorsRecruitingAdherence to Personalized EBM Antihypertensive Drug Prescriptions for Patients With Hypertension and Comorbidities in Everyday Clinical PracticeRussian Federation
-
Center of Personalized Medicine, PirogovaUniversity of Rochester; I.M. Sechenov First Moscow State Medical University; Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health and other collaboratorsCompletedAdherence to Personalized EBM Anticoagulant Treatment in Patients at High Risk for StrokeRussian Federation
-
N.N. Petrov National Medical Research Center of...RecruitingRefusal of Breast Surgery in Patients With Breast Cancer With a cCR After NST and a Confirmed Pathological Complete Response (pCR) Using VAB and SLNBRussian Federation
-
Russian Academy of Medical SciencesCompletedAutism Spectrum Disorder | Language Delay | Language; Developmental Disorder, Expressive | Language; Developmental Disorder, Receptive | Attention Deficit-Hyperactivity Disorder | Speech Disorders in ChildrenRussian Federation
-
AstraZenecaCompletedEGFR Mutation Status in aNSCLC PatientsKorea, Republic of, Russian Federation, Malaysia, China, Australia, Taiwan, Thailand, Indonesia, Singapore
-
AstraZenecaCompletedPostoperative or Postradiation Adjuvant Androgen Deprivation Therapy in Locally Advanced Prostate Cancer (High and Very High Risk) PatientsRussian Federation
-
FibroGenAstraZeneca; Astellas Pharma Europe B.V.CompletedAnemia in Incident Dialysis PatientsRussian Federation, Bulgaria, Thailand, United States, Argentina, Chile, Colombia, Korea, Republic of, Latvia, Malaysia, Mexico, Poland, Romania, Taiwan, Ukraine
-
Novartis PharmaceuticalsCompletedTreatment of Early Pulmonary Infections With P. Aeruginosa in Cystic Fibrosis PatientsEgypt, Greece, Hungary, Russian Federation, Canada, Germany, France, Italy, Switzerland, Romania
-
PfizerTerminatedAvelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid TumorsUnited States, Canada, United Kingdom, Korea, Republic of, Australia, Belgium, Denmark, Hungary, Russian Federation
-
Astellas Pharma Europe B.V.FibroGenCompletedAnemia in Chronic Kidney Disease in Non-dialysis PatientsAustria, Belarus, Bulgaria, Croatia, Czechia, Finland, France, Georgia, Germany, Hungary, Ireland, Israel, Latvia, Montenegro, Netherlands, North Macedonia, Poland, Portugal, Romania, Russian Federation, Serbia, Slovakia, Slovenia, Spain and more
-
Astellas Pharma Europe B.V.FibroGenCompletedAnemia in Chronic Kidney Disease in Non-dialysis PatientsSpain, Belarus, Bulgaria, Hungary, Poland, Romania, Russian Federation, Serbia, Ukraine, United Kingdom, Belgium, Georgia, Italy, Colombia, Dominican Republic, Estonia, Greece, Guatemala, Panama, Peru, South Africa, Turkey
-
Novartis PharmaceuticalsCompletedCytokine Release Syndrome (CRS) in Patients With COVID-19-induced PneumoniaSpain, United States, United Kingdom, Russian Federation, Italy, France